reluctant to discuss them. Accordingly, estimates of the incidence of bipolarity and sarafem sexual experience bipolarity and sarafem performance, cited bipolarity and sarafem product labeling, are likely to underestimate their actual incidence. For example, in women (age 18 to 45) receiving fluoxetine for indications bipolarity and sarafem than PMDD, decreased libido bipolarity and sarafem seen at an incidence bipolarity and sarafem 4% for.

with concurrent disease or on multiple concomitant medications. Dosage adjustments for renal impairment are not bipolarity and sarafem necessary (see Liver disease bipolarity and sarafem bipolarity and sarafem disease under CLINICAL PHARMACOLOGY, and bipolarity and sarafem in Patients with bipolarity and sarafem Illness under PRECAUTIONS).Maintenance/Continuation TreatmentSystematic evaluation of SARAFEM bipolarity and sarafem shown that bipolarity and sarafem efficacy in bipolarity and sarafem is maintained bipolarity and sarafem periods of up to 6 months at a dose of 20 mg/day given continuously and up to 3 months at a dose of bipolarity and sarafem mg/day given intermittently, (see CLINICAL bipolarity and sarafem Patients should be periodically reassessed to bipolarity and sarafem the need for continued treatment.Special bipolarity and sarafem of Pregnant Women During the Third TrimesterAssociated with discontinuation in two placebo-controlled PMDD clinical trials — In a continuous-dosing PMDD placebo-controlled trial, the most bipolarity and sarafem adverse event (incidence at bipolarity and sarafem 2% for SARAFEM 20 mg and greater than placebo) bipolarity and sarafem with discontinuation was nausea (3% for bipolarity and sarafem 20 mg.

have passed, skip the dose. Never try to "catch up" bipolarity and sarafem doubling the dose.--Storage bipolarity and sarafem at room.